Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q79455138
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010857.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q79455138
|
024
|
|
|
‡a
0000-0003-0750-3869
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q79455138
|
100
|
0 |
|
‡a
María I Albarrán
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
María I Albarrán
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's A new destruxin as inhibitor of vacuolar-type H+-ATPase of Saccharomyces cerevisiae
|
670
|
|
|
‡a
Author's Biological characterization of ETP-46321 a selective and efficacious inhibitor of phosphoinositide-3-kinases.
|
670
|
|
|
‡a
Author's Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases
|
670
|
|
|
‡a
Author's Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach.
|
670
|
|
|
‡a
Author's Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors
|
670
|
|
|
‡a
Author's Exome sequencing of plasma DNA portrays the mutation landscape of colorectal cancer and discovers mutated VEGFR2 receptors as modulators of anti-angiogenic therapies.
|
670
|
|
|
‡a
Author's Generation of tricyclic imidazo[1,2-a]pyrazines as novel PI3K inhibitors by application of a conformational restriction strategy.
|
670
|
|
|
‡a
Author's Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor.
|
670
|
|
|
‡a
Author's Identification of novel PI3K inhibitors through a scaffold hopping strategy.
|
670
|
|
|
‡a
Author's Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTOR.
|
909
|
|
|
‡a
(orcid) 0000000307503869
‡9
1
|
919
|
|
|
‡a
identificationofnovelpi3kinhibitorsthroughascaffoldhoppingstrategy
‡A
Identification of novel PI3K inhibitors through a scaffold hopping strategy.
‡9
1
|
919
|
|
|
‡a
rapididentificationofetp46992orallybioavailablepi3kinhibitorselectiveversusmtor
‡A
Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTOR.
‡9
1
|
919
|
|
|
‡a
newdestruxinasinhibitorofvacuolartypeh+atpaseofsaccharomycescerevisiae
‡A
A new destruxin as inhibitor of vacuolar-type H+-ATPase of Saccharomyces cerevisiae
‡9
1
|
919
|
|
|
‡a
biologicalcharacterizationofetp46321aselectiveandefficaciousinhibitorofphosphoinositide3kinases
‡A
Biological characterization of ETP-46321 a selective and efficacious inhibitor of phosphoinositide-3-kinases.
‡9
1
|
919
|
|
|
‡a
chemicalinterrogationoffoxo3anucleartranslocationidentifiespotentandselectiveinhibitorsofphosphoinositide3kinases
‡A
Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases
‡9
1
|
919
|
|
|
‡a
discoveryofmitogenactivatedproteinkinaseinteractingkinase1inhibitorsbyacomprehensivefragmentorientedvirtualscreeningapproach
‡A
Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach.
‡9
1
|
919
|
|
|
‡a
discoveryofnoveltriazolopyridazin3ylquinolinederivativesaspiminhibitors
‡A
Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors
‡9
1
|
919
|
|
|
‡a
exomesequencingofplasmadnaportraysthemutationlandscapeofcolorectalcanceranddiscoversmutatedvegfr2receptorsasmodulatorsofantiangiogenictherapies
‡A
Exome sequencing of plasma DNA portrays the mutation landscape of colorectal cancer and discovers mutated VEGFR2 receptors as modulators of anti-angiogenic therapies.
‡9
1
|
919
|
|
|
‡a
generationoftricyclicimidazopyrazinesasnovelpi3kinhibitorsbyapplicationofaconformationalrestrictionstrategy
‡A
Generation of tricyclic imidazo[1,2-a]pyrazines as novel PI3K inhibitors by application of a conformational restriction strategy.
‡9
1
|
919
|
|
|
‡a
identificationofetp46321apotentandorallybioavailablepi3kαδinhibitor
‡A
Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor.
‡9
1
|
996
|
|
|
‡2
BNE|XX844823
|
996
|
|
|
‡2
SUDOC|135464528
|
996
|
|
|
‡2
PTBNP|3258
|
996
|
|
|
‡2
LC|n 2024019674
|
996
|
|
|
‡2
RERO|A022432026
|
996
|
|
|
‡2
ISNI|0000000093118980
|
996
|
|
|
‡2
BNE|XX1637707
|
996
|
|
|
‡2
BNE|XX5480218
|
996
|
|
|
‡2
DNB|1157325270
|
996
|
|
|
‡2
BNC|981058509190906706
|
996
|
|
|
‡2
LC|no2011154053
|
996
|
|
|
‡2
DNB|171692659
|
996
|
|
|
‡2
BNC|981058520359606706
|
996
|
|
|
‡2
BNC|981058524789206706
|
996
|
|
|
‡2
NII|DA15003035
|
996
|
|
|
‡2
ISNI|0000000061114838
|
996
|
|
|
‡2
BNE|XX1725227
|
996
|
|
|
‡2
RERO|A003425775
|
996
|
|
|
‡2
ISNI|000000006043926X
|
996
|
|
|
‡2
PLWABN|9810683240705606
|
996
|
|
|
‡2
BNE|XX4819945
|
996
|
|
|
‡2
CAOONL|ncf11237647
|
996
|
|
|
‡2
BNE|XX1666851
|
996
|
|
|
‡2
ISNI|0000000069519637
|
996
|
|
|
‡2
BNF|16672097
|
996
|
|
|
‡2
LC|no2010091870
|
996
|
|
|
‡2
CAOONL|ncf13719631
|
996
|
|
|
‡2
ISNI|0000000059433530
|
996
|
|
|
‡2
ERRR|a11529593
|
996
|
|
|
‡2
ISNI|0000000498660823
|
996
|
|
|
‡2
LC|no2017135713
|
996
|
|
|
‡2
LC|n 92069467
|
996
|
|
|
‡2
ISNI|0000000060880995
|
996
|
|
|
‡2
ISNI|0000000080464016
|
996
|
|
|
‡2
SUDOC|057199132
|
996
|
|
|
‡2
NTA|19199359X
|
996
|
|
|
‡2
ISNI|0000000139105668
|
996
|
|
|
‡2
ISNI|0000000067682430
|
996
|
|
|
‡2
DNB|1057500542
|
996
|
|
|
‡2
SUDOC|179848569
|
996
|
|
|
‡2
SUDOC|151856648
|
996
|
|
|
‡2
BNC|981060981472506706
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|